 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Special
thanks for their unrestricted support of this website. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A World Leader
Stanford Interventional Cardiology is a world leader in percutaneous coronary revascularization. We perform over 1000 interventions per year and offer the latest breakthroughs in the treatment of coronary artery disease and valvular heart disease.
Our site will be updated regularly and parts of it are currently under construction. We apologize for any inconvenience this may cause. Feel free to give us feedback on our site and let us know what topics you would like to see.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
What's new |
|
|
|
|||||
|
|||||
Drug-eluting Sent
Conference at Stanford |
|||||
|
|||||
|
|||||
|
|||||
We are offering new services including ASD and PFO closures and alcohol septal ablation for hypertrophic cardiomyopathy. Call us for details! |
|||||
|
|||||
|
|||||
|
|||||
Clinical Trials Update! New and ongoing clinical trials with novel embolic protection devices, etc..... |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
